PTEN assessment and PI3K/mTOR inhibitors: Importance of simultaneous assessment of MAPK pathway aberrations.
暂无分享,去创建一个
R. Broaddus | R. Kurzrock | Vanda M. Stepanek | F. Janku | A. Naing | D. Hong | J. Wheler | S. Piha-Paul | A. Tsimberidou | S. Moulder | R. Luthra | G. Falchook | S. Fu | R. Bakkar